Latest Announcements

The Board of Directors of Neueon Corporation Limited has approved the shifting of the company's registered office from Survey No. 321, Turkala Khanapur Village, Hathnoora Mandal, Sangareddy District, Telangana - 502296, India to 204, Second Floor, Ashoka Capital, Road No. 2, Banjara Hills, Hyderabad - 500034, Telangana, India. The company has also approved the draft Board's Report for the FY 2025-26, fixed the date of the 19th Annual General Meeting, and approved the draft Notice of the meeting. Additionally, the company has announced a rights issue to eligible equity shareholders to raise funds for minimum public shareholding.

Dhunseri Ventures Limited has informed the exchange about general updates, including the web-link for the notice of the 110th Annual General Meeting and communication of deduction of tax at source on dividend for the FY 2025-26.

Bank of India has informed the Exchange about the change in management, with Shri Prashant Thapliyal, Chief General Manager, being relieved from service upon superannuation on 31.07.2026.

Star Health and Allied Insurance Company Limited has scheduled an analyst/investor meeting on August 06, 2026, in Hong Kong, with three firms: Polymer Capital Management, Schroder Investment Management, and Zaaba Capital.

KIOCL Limited has observed a significant increase in volume, prompting the exchange to write to the company for clarification, with the company's response awaited.

Khaitan (India) Limited has submitted its financial results for the period ended June 30, 2026, following a board meeting.

NSE-listed Sheetal Cool Products Limited has seen a significant increase in trading volume, prompting the exchange to write to the company for clarification, awaiting a response.

Styrenix Performance Materials Limited has scheduled an earnings call to discuss its unaudited standalone and consolidated financial results for Q1 FY27 on August 5, 2026.

SMS Pharmaceuticals Limited has announced its record date for the purpose of dividend as 16-Sep-2026. The company has also approved its standalone and consolidated un-audited financial results for the first quarter ended 30th June, 2026, and has fixed the record date for the 38th Annual General Meeting (AGM) as 16th September, 2026.

ESAF Small Finance Bank reported strong Q1 FY27 results with PAT at ₹80 Crore, total business crossing ₹50,000 Crore, and asset quality strengthening with NNPA at 0.8%.

Genesys International Corporation Limited has announced the record date for its rights issue, which will be on August 6, 2026. The rights issue will offer 2,50,74,226 fully paid-up equity shares of face value of ₹ 5 each at a price of ₹ 50 each, including a premium of ₹ 45 per share. The issue will be open from August 14 to August 21, 2026.

Eveready Industries India Limited has announced the schedule of its Q1FY27 Earnings Conference Call, to be held on August 10, 2026, at 4:30 pm IST.

TVS Motor Company Limited has informed the Exchange about a copy of newspaper publication regarding a special window for transfer and dematerialisation of physical securities.

CORONA Remedies Limited has announced its unaudited financial results for Q1FY27, reporting a revenue growth of 21.9% and a PAT growth of 30.1% Y-o-Y, driven by robust brand building and operational excellence.

Genesys International Corporation Limited has announced a rights issue of 2,50,74,226 equity shares at Rs. 50 per share, with a record date of August 06, 2026, and a rights entitlement ratio of 3:5.

Sumit Woods Limited has informed the Exchange regarding Notice of Postal Ballot to seek shareholders' consent for related party transactions, remuneration of CFO and MD, and other resolutions.

Ajooni Biotech Limited has informed the Exchange about an increase in its authorized capital from Rs. 35,00,00,000 to Rs. 70,00,00,000, with the number of equity shares increasing from 17,50,00,000 to 35,00,00,000, following approval at its 16th Annual General Meeting.

Ajooni Biotech Limited has informed the Exchange about the issuance of 90,00,000 equity shares on a preferential basis, approved by the members at the 16th Annual General Meeting.

Ajooni Biotech Limited has informed the Exchange about the re-appointment of Mr. Gursimran Singh as Director who retires by rotation, as approved by the 16th Annual General Meeting of the company.

Ajooni Biotech Limited has informed the Exchange regarding the Amendment to AOA/MOA of the company, where the members have approved the increase in Authorised Share Capital and Amendment of Capital Clause of the Memorandum of Association.